ArticleCell reports. Medicine2025

Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation.

Yan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.